930790-43-5 Usage
Uses
Used in Pharmaceutical Industry:
7-CHLORO-5-METHYL-1H-PYRROLO[2,3-C]PYRIDINE is used as a building block for the synthesis of new drug candidates due to its unique chemical structure and potential biological activity. It may contribute to the development of novel therapeutic agents for various medical conditions.
Used in Agrochemical Industry:
7-CHLORO-5-METHYL-1H-PYRROLO[2,3-C]PYRIDINE is used as a precursor in the production of crop protection agents. Its chemical properties can be harnessed to create effective compounds for pest control and crop enhancement, contributing to improved agricultural productivity and crop protection.
Used in Material Science:
7-CHLORO-5-METHYL-1H-PYRROLO[2,3-C]PYRIDINE may find applications in material science due to its heterocyclic structure and potential for chemical modifications. It could be utilized in the development of new materials with specific properties, such as improved stability, reactivity, or selectivity, for various industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 930790-43-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,0,7,9 and 0 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 930790-43:
(8*9)+(7*3)+(6*0)+(5*7)+(4*9)+(3*0)+(2*4)+(1*3)=175
175 % 10 = 5
So 930790-43-5 is a valid CAS Registry Number.
930790-43-5Relevant academic research and scientific papers
Heterobicyclic amide compounds
-
Page/Page column 9, (2010/11/28)
Compounds of formula I processes for their preparation and pharmaceutical compositions comprising them.
Phenylaminopropanol derivatives and methods of their use
-
Page/Page column 57, (2010/11/26)
The present invention is directed to phenylaminopropanol derivatives of formulae I, II, and III: [image] or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, schizophrenia, and combinations thereof.
